| Normal | DGM | P value |
---|---|---|---|
Group size | (n = 219) | (n = 119) |  |
Baseline characteristics | Â | Â | Â |
 Sex |  |  |  |
 Men | 131 (59.8 %) | 92 (77.3 %) | 0.001 |
 Women | 88 (40.2 %) | 27 (22.7 %) | |
 Age, years | 57 (18–88) | 67 (29–83) | <0.001 |
 Weight, kg | 75 ± 14 | 80 ± 16 | 0.003 |
 Body mass index, kg/m2 | 25 (16–41) | 26 (18–41) | 0.002 |
 Waist, cm | 93 (66–124) | 99 (66–133) | <0.001 |
Reason for admission | Â | Â | Â |
 Medical | 84 (38.4 %) | 33 (27.7 %) | NS |
 Surgical | 135 (61.6 %) | 86 (72.3 %) | |
Primarily involved organ system | Â | Â | Â |
 Cardiovascular | 108 (49.3 %) | 71 (59.7 %) | NS |
 Respiratory | 46 (21.0 %) | 20 (16.8 %) | NS |
 Digestive | 16 (7.3 %) | 6 (5.0 %) | NS |
 Renal | 4 (1.8 %) | 3 (2.5 % | NS |
 Hepatic | 8 (3.7 %) | 3 (2.5 %) | NS |
 Haematologic | 2 (0.9 %) | 0 (0.0 %) | NS |
 Neurologic | 53 (24.2 %) | 19 (16.0 %) | NS |
Disease severity | Â | Â | Â |
 Simplified acute physiology score III | 42 (16–90) | 42 (23–85) | NS |
 SOFA score on admission | 8 (1–18) | 8 (2–19) | NS |
 Maximum SOFA score during admission | 8 (2–20) | 8 (2–19) | NS |
 Vasopressor/inotropic therapy | 120 (54.8 %) | 79 (66.4 %) | 0.039 |
 Corticosteroid therapy | 35 (16.0 %) | 12 (10.1 %) | NS |
 Mechanical ventilation | 134 (61.2 %) | 73 (61.3 %) | NS |
 Length of stay at the ICU, hours | 95 (39–1416) | 94 (37–503) | NS |
 Length of stay at the hospital, days | 15 (3–163) | 14 (2–86) | NS |
Metabolic parameters | Â | Â | Â |
 Mean glycaemia, day 1, mg/dl | 130 (83–469) | 130 (86–232) | NS |
 SD glycaemia, day 1 | 22 (1–615) | 22 (4–168) | NS |
 Maximum glycaemia, day 1, mg/dl | 168 (87–591) | 166 (86–600) | NS |
 Number of patients with hypoglycaemic event, day 1 | 11 (5.1 %) | 7 (5.9 %) | NS |
 glucose values in target, 60–140 mg/dl (%, range) | 70 (0–100) | 67 (14–100) | NS |
 Mean (SD) glycaemia, mg/dl | 128 (18) | 131 (27) | NS |
 Median (IQR) glycaemia, mg/dl | 129 (120–137) | 130 (117–140) | NS |
 SD glycaemia levels in individual patients, mg/dl, median (range) | 27 (19–34) | 30 (21–40) | NS |
 HbA1c on admission, (%) | 5.5 (4.7–6.2) | 5.6 (5.0–6.4) | 0.025 |
 HbA1c on admission, (mmol/mol) | 37 (28–44) | 38 (31–46) |  |
 Insulin therapy | 153 (69.9 %) | 93 (78.2 %) | NS |
 Mean insulin dose, units/day | 9 (0–100) | 12 (0–99) | 0.048 |
 Total parental nutrition | 15 (6.8 %) | 1 (0.8 %) | 0.013 |
 Caloric intake, kcal/day | 222 (0–2127) | 197 (32–1911) | 0.013 |
ICU exit parameters | Â | Â | Â |
 C-reactive protein, last day, mg/l | 5.7 (0.0-30.0) | 8.1 (0.0-29.0) | 0.015 |
 Lactate, last day, mmol/l | 1.3 (0.4-79.0) | 1.5 (0.7-4.0) | 0.006 |
 Mean glucose last day, mg/dl | 115 (84–164) | 122 (82–217) | <0.001 |
 Maximum glucose, last day, mg/dl | 136 (91–438) | 157 (94–636) | 0.001 |
FINDRISC score | 9.5 (0–20) | 11 (3–21) | <0.001 |
FINDRISC score ≥14 | 30 (14.3 %) | 33 (28.2 %) | 0.003 |
HbA1c upon OGTT, (%) | 5.4 (4.3-6.1) | 5.6 (4.9-8.4) | <0.001 |
HbA1c upon OGTT, (mmol/mol) | 36 (23–43) | 38 (30–68) |  |
HbA1c ≥6.5 % upon OGTT | 0 | 5 (4.2 %) | 0.005 |